Cigna: Scrutiny of the PXDX algorithm in 2024 for bulk denial of claims without review

Investigative Fan Out: Twenty Questions on the PXDX Data

We examine the core metrics and legal actions surrounding the Cigna PXDX system.

1. What is the PXDX system? It is a procedure to diagnosis matching software used by Cigna to approve or deny claims.
2. What does PXDX stand for? The acronym stands for procedure to diagnosis.
3. How report claims did Cigna deny over two months in 2022? The company denied 300, 000 claims.
4. What was the average review time per claim? Medical directors spent an average of 1. 2 seconds per claim.
5. How report claims did a single medical director deny in one month? One director denied 60, 000 claims in a 30 day period.
6. When did ProPublica publish its investigation? The news organization published the report in March 2023.
7. Did Cigna doctors open patient files before denying these claims? Court filings allege doctors did not open individual patient files.
8. What percentage of denied claims do patients appeal? Federal data shows patients appeal only 0. 2 percent of denied claims.
9. Which federal committee investigated Cigna after the report? The House Energy and Commerce Committee launched an inquiry.
10. When did Andrew Sachs file a lawsuit against Cigna? He filed the lawsuit on March 11, 2024.
11. Where was the Sachs lawsuit filed? The lawsuit was filed in a Connecticut federal court.
12. What did the March 2025 court ruling decide? A federal judge allowed breach of fiduciary duty claims to proceed against Cigna.
13. Which judge allowed the California class action to proceed? U. S. District Judge Dale Drozd issued the ruling.
14. What specific services does PXDX process? The system processes 50 inexpensive services like vitamin D screenings and chemical peels.
15. Does Cigna classify PXDX as artificial intelligence? Cigna representatives state the software does not use artificial intelligence or machine learning.
16. How report claims are sent to a physician at one time for review? The system sends up to 50 claims in a single batch.
17. What state law did the California lawsuit accuse Cigna of violating? Plaintiffs accused Cigna of violating the California Unfair Competition Law.
18. Did Cigna deny the allegations in the ProPublica report? Cigna published a statement calling the report factually incorrect.
19. What is the financial result of the PXDX system on Cigna? The exact dollar amount remains undisclosed in court filings.
20. What is the primary complaint of the plaintiffs? Plaintiffs allege Cigna bypassed legally required individual physician reviews.

The 300, 000 Claim Denial Dataset

In March 2023, investigative journalists at ProPublica published a report detailing the internal claims processing metrics at Cigna. The data revealed that Cigna used a proprietary software system known as PXDX to process and deny medical claims. The acronym stands for procedure to diagnosis. The software evaluates whether a submitted medical procedure matches the approved diagnosis codes set by corporate policies. If the software detects a mismatch, it routes the claim to a medical director for denial.

The dataset obtained by reporters showed that over a two month period in 2022, Cigna medical directors denied 300, 000 requests for payment. The internal tracking spreadsheets indicated that the average time spent reviewing each denied claim was 1. 2 seconds. In one instance, a single Cigna medical director signed off on 60, 000 claim denials within a 30 day window. Medical professionals and legal experts immediately questioned whether a human could conduct a thorough medical review in just over one second.

Cigna representatives responded to the publication by stating the software does not use artificial intelligence or machine learning. The company explained that PXDX processes 50 specific inexpensive services, including vitamin D screenings and chemical peels. According to corporate statements, the system batches up to 50 incorrectly coded claims at a time and sends them to a physician for final signature. Cigna maintained that this process accelerates payments for correctly coded claims and follows standard industry practices.

Following the publication of the claims data, the House Committee on Energy and Commerce initiated a formal inquiry. Representative Cathy McMorris Rodgers sent a letter to Cigna demanding answers about the PXDX review process. The committee expressed concern that the software forces policyholders to pay out of pocket for medical care that their insurance contracts should cover. State insurance commissioners also reacted to the data. Mike Kreidler, the insurance commissioner for Washington, publicly criticized the company and stated it is unacceptable to routinely deny claims just to enhance the bottom line.

Operational Mechanics of the Procedure to Diagnosis Software

The PXDX software operates as a filtering tool within the Cigna claims processing infrastructure. When a healthcare provider submits a claim, the system cross

The Origins of the Procedure to Diagnosis Algorithm

Dr. Alan Muney designed the PXDX system for Cigna over a decade ago. Muney is a former pediatrician who previously advised private equity firms on cost savings. He worked as an executive at Blackstone in 2010. His primary objective involved identifying operational savings for health insurance companies. Muney previously helped develop a similar bulk denial system during his tenure at UnitedHealthcare. He brought this framework to Cigna to reduce the expenses associated with traditional manual claim reviews. The traditional method required a nurse and a medical director to evaluate each patient file individually. The PXDX system bypassed this requirement by automatically matching submitted claims against a predetermined list of approved conditions. Claims failing to meet these exact parameters went directly to medical directors for bulk rejection.

The architecture of this system relies on high volume processing. Medical directors receive batches of denied claims and apply their electronic signatures. They do not open individual patient files or review medical records before signing. Muney confirmed to reporters that the system intentionally circumvents traditional medical review. He stated the process saved the company billions of dollars. The algorithm flags the mismatch. The medical director provides the legal authorization to deny payment. State regulators in Maryland and other jurisdictions questioned the legality of this automated system. Regulators demanded investigations to determine if the software complies with state insurance laws.

The Productivity Dashboard and Offshore Approvals

Corporate records from early 2022 show Cigna tracked the speed of its medical directors. The company maintained a productivity dashboard to monitor how quickly doctors cleared PXDX cases. An April 2024 investigation revealed that Cigna management warned medical directors about slow decision times. Executives told one medical director that her slow turnaround time could lead to her termination. The dashboard ranked medical directors based on their average time per claim decision.

The internal workflow separated approvals from denials. Nurses located in the Philippines held the authority to approve payments for medical care. Denials required the signature of a medical director based in the United States. This structure concentrated the denial workload onto a small group of domestic physicians. These doctors faced corporate pressure to maintain high clearance rates on the productivity dashboard. The system prioritized speed over individualized medical assessment. The metrics created an environment where thorough medical review became mathematically impossible for the assigned doctors.

The Signatories Executing Bulk Rejections

The exact volume of claims processed by individual doctors highlights the mechanics of the PXDX system. Dr. Cheryl Dopke served as a Cigna medical director. Internal records from 2022 show Dopke signed approximately 60, 000 claim denials in a single month. Another Cigna medical director authorized more than 80, 000 instant denials during the same period. These figures equate to over 2, 000 rejections per day for a single physician. The doctors executed these denials in batches of fifty at a time. One former medical director stated the batch submission process took exactly ten seconds to complete.

Dr. Nick van Terheyden experienced this process firsthand. His physician ordered a blood test to confirm a vitamin D deficiency. Cigna denied the claim as not medically required. Dopke signed the denial letter. Van Terheyden is a medical specialist himself. He suspected the medical director never reviewed his file. He appealed the decision through the external review process. An independent physician evaluated the case and determined the blood test was medically required. Cigna later reversed the denial. Corporate data indicates that only 5 percent of patients appeal a PXDX denial. The remaining 95 percent either pay the bill themselves or cancel their medical procedures. Cigna added an autonomic nervous system test to the PXDX list to detect nerve damage from diabetes. The company calculated this single addition would deny 17, 800 claims annually and save 2. 4 million dollars.

2024 Legal Actions and Corporate Defense

Policyholders filed class action lawsuits against Cigna in 2023 and 2024. Suzanne Kisting Leung and other plaintiffs sued the company in the United States District Court for the Eastern District of California. The plaintiffs allege Cigna uses the PXDX algorithm to automatically reject claims without the individual physician review required by state law. The third amended complaint filed in June 2024 report that Cigna policies falsely state a medical director determines medical need. The plaintiffs claim the algorithm makes the actual determination. The lawsuit asserts that Cigna knows only 0. 2 percent of policyholders appeal denied claims.

Cigna aggressively defended the PXDX system in federal court throughout 2024. The company filed motions to dismiss the Kisting Leung lawsuit. Cigna lawyers state the plaintiffs fundamentally misunderstand how the claims review process works. The company asserts that PXDX does not make medical need determinations. Cigna claims the system only checks whether specific treatments are covered by the benefit plan of the member. Dr. Julie Kessel submitted a declaration in August 2024 supporting the motion to dismiss. Kessel stated that the PXDX system did not process the claims of three specific plaintiffs in the lawsuit. Cigna states these plaintiffs do not have standing to sue.

The legal filings reveal a dispute over the exact function of the medical directors. Plaintiffs claim the doctors act as a rubber stamp for an automated system. Cigna maintains the doctors perform a valid administrative function. The company states there is no financial incentive for medical directors to deny claims. The court continues to weigh the motions to dismiss as of late 2024. A separate lawsuit filed by Paige Van Pelt in Connecticut mirrored the California claims. Van Pelt alleged Cigna denied her medically required colonoscopy through the PXDX system. She later withdrew her lawsuit voluntarily.

Monthly Denial Volume by Cigna Medical Directors in 2022

The Eastern District Venue and the Initial Filings

On July 24, 2023, a coalition of patients filed a putative class action lawsuit in the United States District Court for the Eastern District of California. The plaintiffs targeted Cigna Corporation and Cigna Health and Life Insurance Company over the deployment of the PXDX algorithm. The legal action centers on the allegation that the insurer bypassed mandated medical reviews to deny claims in bulk. Court documents outline that the company covers roughly 2. 1 million members in California and administers health plans for 18 million people nationwide. The lawsuit seeks to represent any individual who purchased a Cigna plan in the state over a four year period. The plaintiffs demand monetary damages and a formal injunction to stop the company from using the software for claims management.

The third amended complaint lists multiple plaintiffs. The roster includes Suzanne Kisting Leung, Samantha Dababneh, Randall Rentsch, Christina Thornhill, Amanda Bredlow, Abdulhussein Abbas, and Ayesha Smiley. The filings detail specific medical procedures denied by the automated system. Kisting Leung received a denial for an ultrasound procedure ordered to assess her risk for ovarian cancer. Smiley faced a denial for a routine Vitamin D deficiency test. The plaintiffs state that Cigna delegated its fiduciary obligation to evaluate these claims to the PXDX software. The algorithm flags mismatches between a diagnosis code and a list of acceptable tests. Cigna applies this system to approximately 50 low cost tests and procedures to verify billing codes.

State Law and the Fiduciary Breach Allegations

The legal challenge relies heavily on California Health and Safety Code Section 1367. 01(e). This state law mandates that no individual other than a licensed physician or a competent health care professional may deny or modify requests for medical justification. The plaintiffs contend the automated batch processing violates this statute directly. They also brought claims under the California Unfair Competition Law and the Employee Retirement Income Security Act. The core argument asserts that Cigna breached its implied covenant of good faith and fair dealing by falsely claiming a medical director reviewed the claims. The lawsuit states that medical directors signed off on batches of hundreds or thousands of denials at a time without opening individual patient files.

The speed of the automated denials forms the foundation of the legal argument. The plaintiffs state that the rapid processing time makes it physically impossible for claims to receive individual review. California law requires medical professionals to conduct a thorough and objective investigation of every claim. The complaint alleges Cigna fraudulently misled its members into believing the company would individually decide their claims and pay for medically justified procedures. The plaintiffs maintain the software acts as a blockade to care and leaves thousands of patients with unexpected medical bills.

Defense Strategy and Corporate Justification

Cigna filed multiple motions to dismiss the lawsuit throughout 2023 and 2024. The insurer claimed that the plaintiffs failed to plead facts showing a fraudulent scheme. The company maintained that it acted within its discretionary authority to interpret plan terms and use the algorithm for claims review. Defense attorneys stated that the PXDX system is a standard review process similar to methods used by other payers across the medical sector. Cigna also claimed it sends disclosures to both the doctor and the patient whenever the PXDX system processes a claim. The defense characterized the allegations as a fundamental misunderstanding of the claims review architecture.

The corporate legal team pushed back against the narrative that the software practices medicine. Cigna representatives stated that the algorithm does not use artificial intelligence to review claims. They described the system as a simple matching tool that verifies whether a submitted billing code aligns with the approved diagnosis criteria. The company asserted that the system expedites physician reimbursement for approved claims and does not result in actual care denials. The defense insisted that patients retain the right to appeal any decision generated by the software.

The March 2025 Judicial Ruling

On March 31, 2025, U. S. District Judge Dale Drozd delivered a mixed ruling on the motion to dismiss. The judge allowed several claims to proceed. He found that Cigna abused its discretion by interpreting plan terms to permit automated medical justification decisions. The court determined the plaintiffs adequately pleaded a violation of the California code provision under the Unfair Competition Law. Judge Drozd ruled that the Employee Retirement Income Security Act does not expressly preempt the state law claim because it falls under a savings clause that exempts certain state insurance regulations.

The court agreed with the plaintiffs that delegating medical justification decisions to the automated algorithm violated the specific terms of the health plans. The governing documents required a review of medical justification claims by a medical director. The judge ruled that the automated batch processing did not satisfy this contractual requirement. This decision allows the plaintiffs to move forward with their federal claims and seek restitution for the denied benefits.

The Standing Dispute and Evidentiary load

The March 2025 order also delivered a partial victory to Cigna regarding plaintiff standing. The defense mounted a factual attack against three specific plaintiffs. Cigna submitted an affidavit from medical officer Dr. Julie B. Kessel. The affidavit stated that the PXDX algorithm did not process the specific claims filed by Kisting Leung, Thornhill, and Bredlow. Judge Drozd ruled that these three individuals could not prove the algorithm caused their specific denials. The court dismissed their specific counts related to the algorithm report granted the plaintiffs 21 days to amend their complaint.

This ruling forces the legal teams to substantiate exactly which claims passed through the automated system versus standard manual review. The plaintiffs dropped two of four California state law claims to focus on the federal regulations. The surviving unjust enrichment claims supplement the federal arguments. The legal proceedings demand concrete proof of algorithmic involvement in each denied claim. The requirement to trace the exact adjudication route of a single medical bill adds a heavy evidentiary requirement to the class action.

Litigation Metrics and Timeline

The progression of the Eastern District lawsuit provides a clear timeline of the legal battle over automated adjudication. The court docket reveals the specific dates and figures associated with the case.

The Eastern District litigation sets a clear boundary for automated claims processing. The court decision establishes that delegating medical justification determinations to software can constitute a fiduciary breach if the health plan terms require a medical director review. The case continues to move through the discovery phase. The legal teams must report gather the internal data logs to prove exactly how the software processed the remaining plaintiffs medical bills. The outcome of this discovery process dictates the financial liability Cigna faces under the Employee Retirement Income Security Act. The court demands precise documentation showing the exact timestamp and routing of each denied claim to verify whether a human medical director or the PXDX algorithm executed the final rejection. This granular level of data extraction sets a new standard for transparency in automated health care adjudication.

The Financial Logic Behind the Selected Codes

Cigna applies its procedure to diagnosis matching software to approximately 50 specific medical tests and treatments. The company focuses the algorithm on low cost, high volume procedures. These tests cost a few hundred dollars each on average. Former executives noted that patients denied a $75 or $200 bill are highly unlikely to hire a lawyer or navigate a complex appeals process. Internal corporate presentations estimated that only five percent of patients would appeal a denial generated by the system. By aggregating hundreds of thousands of small rejections, the insurer retains millions of dollars in revenue without triggering massive legal pushback from individual policyholders. Dr. Alan Muney originally developed this review system over a decade ago. He previously advised private equity firms on cost savings before helping Cigna identify financial retention strategies. In 2010, Muney helped the insurer identify savings in its operation while managing health insurance for companies owned by Blackstone, a major private equity firm. The resulting software automates the rejection of claims that previously required a manual review by a medical director. The system allows medical directors to reject claims in bulk, signing off on batches of fifty denials in seconds. This method bypasses the conventional claim review process where a medical professional examines a patient chart to determine actual medical need.

Vitamin D Screenings

Blood tests for vitamin D deficiency represent one of the most frequently flagged categories in the Cigna system. Medical providers bill these screenings under specific Current Procedural Terminology codes. The algorithm automatically rejects claims if the submitted diagnostic code does not perfectly align with a predetermined list of approved conditions. Cigna stated there are more than 200 acceptable diagnosis codes for this test, yet any deviation results in an instant denial. The company justifies this by citing American Board of Internal Medicine research stating the test is not medically justified without specific indicators. In one documented case, a patient named Nick van Terheyden received a denial for a vitamin D blood test ordered by his physician to check for a deficiency that leads to bone fractures. The system rejected the claim because the specific diagnostic code did not match the rigid internal criteria. Patients are then left to pay the bill out of pocket.

Autonomic Nervous System Testing

In 2014, Cigna executives evaluated adding autonomic nervous system testing to the automated denial list. Doctors use this noninvasive, hour long procedure to detect nerve damage caused by diabetes or autoimmune diseases. The test involves checking heart rate, sweat response, equilibrium, and other basic body functions. Before the algorithm update, the insurer paid for the nerve test without a manual review. Corporate documents projected that adding the procedure to the automated system would generate more than 17,800 denials annually. The internal presentation acknowledged this move would create a negative customer experience and increase out of pocket costs for patients. The company proceeded with the addition because the automated rejections would save an estimated $2.4 million per year in medical payouts.

Financial Projections for Autonomic Nervous System Testing Denials

Routine and Screening Ultrasounds

The algorithm also flags specific ultrasound procedures. A 2023 class action lawsuit filed in the Eastern District of California detailed a plaintiff who received a denial for an ultrasound. The patient underwent the procedure after a medical professional identified her as being at risk for ovarian cancer. The software flagged the claim as a mismatch between the procedure code and the approved diagnostic codes. The system rejected the payment instantly. The speed of the automated review meant no medical director looked at the patient file to understand the cancer risk before issuing the denial. The lawsuit states this automated rejection process violates California state law, which requires health insurance companies to conduct thorough, fair, and objective investigations of bills submitted for medical expenses.

Dermatological Treatments: Dermabrasion and Chemical Peels

Cigna explicitly lists dermabrasion and chemical peels as procedures subjected to the automated review process. Medical providers bill dermabrasion under codes 15780 through 15783. The company defends this practice by stating these treatments are only medically justified under very specific diagnoses. Insurance guidelines frequently classify these procedures as cosmetic rather than reconstructive unless the patient presents a specific, approved medical condition. If a dermatologist submits a claim for a chemical peel to treat a severe skin condition, the billing code must match the exact ICD 10 diagnostic code required by the internal policy. A minor coding variation triggers an automatic rejection. The system does not allow a physician to explain the medical need in a peer review discussion before the denial is issued. The software simply matches the numbers and outputs a rejection.

Diagnostic Swallowing Studies

Procedure to diagnosis edits frequently affect diagnostic evaluations like swallowing studies for dysphagia. Medical providers use swallowing studies to prevent aspiration pneumonia in stroke patients or individuals with neurological disorders. Clinics bill these complete procedures under codes 70370, 70371, and 74230. Medicare and private insurers require specific secondary diagnosis codes, such as the I69 series for dysphagia following a cerebrovascular disease. If the secondary diagnosis code is missing or misaligned, the software denies the service as not medically justified. The automated system does not read the clinical notes detailing the patient inability to swallow. It relies entirely on the presence of the exact alphanumeric code combination to approve the payment.

Urine Drug Monitoring

Automated systems across the insurance industry increasingly flag urine drug tests. Providers use these tests to monitor patients on specific pain management regimens or to check for substance abuse. When the algorithm detects a mismatch between the screening code and the approved diagnosis list, it rejects the claim. The financial load then falls entirely on the medical provider to resubmit the claim with different codes or abandon the payment altogether. Clinics processing high volumes of these tests face massive administrative backlogs when the software denies batches of claims simultaneously. The automated edits force medical billers into a continuous loop of resubmissions to find the exact code combination the software requires for approval.

Reconstructive Surgeries: Rhinoplasty and Abdominoplasty

The procedure to diagnosis matching logic extends to surgeries that blur the line between cosmetic and reconstructive care. Procedures like rhinoplasty and abdominoplasty face strict automated edits. Medical providers perform rhinoplasty to improve abnormal function, reconstruct congenital deformities, or repair acquired injuries. Current billing codes do not allow a simple distinction between a cosmetic alteration and a reconstructive requirement. The categorization relies entirely on the presence or absence of specific diagnostic signs submitted alongside the surgical code. If a surgeon submits a claim for a septoplasty to correct a breathing obstruction, the software cross

The Financial Architecture of Automated Denials

The business logic behind batch processing relies on a simple mathematical foundation. Every denied claim represents revenue retained by the insurer. When a company denies a medical request, the financial advantage depends entirely on the patient abandoning the appeal. A survey by the non-profit KFF found that fewer than 0. 2 percent of people purchasing insurance through HealthCare. gov appeal their denied in-network claims. This low appeal rate allows insurers to avoid payment on the vast majority of rejected claims. The algorithm does not need perfect accuracy. It only needs to generate a high volume of rejections to secure substantial cost reductions.

Internal documents from Cigna demonstrate the precise financial calculations tied to the PXDX system. In one specific presentation, company officials estimated the financial impact of adding a single nerve test to the automated rejection list. The documents show the insurer expected to turn down more than 17, 800 claims a year for this specific test. The presentation acknowledged this action would create a negative customer experience and increase out-of-pocket costs for patients. Yet the same presentation calculated this single addition would save the company roughly $2. 4 million a year in medical costs. Dr. Alan Muney, the former executive who developed the PXDX system, stated that such automated formulas have undoubtedly saved billions of dollars across the private insurance industry.

Cigna reported massive financial gains during the period it expanded its automated review systems. In 2023, Cigna Healthcare recorded adjusted revenues of $51. 2 billion and a pre-tax adjusted income from operations of $4. 5 billion. The financial momentum continued into the third quarter of 2024, when the company reported $69. 7 billion in revenue. In January 2024, Cigna entered an agreement to sell its Medicare Advantage business to Health Care Service Corporation for $3. 3 billion in cash. These figures highlight the immense capital generated while the company deployed software to minimize medical payouts.

Industry Wide Algorithmic Suppression Metrics

The financial incentives driving automated denials extend far beyond Cigna. A 2024 United States Senate report examined the use of predictive technologies among the three largest Medicare Advantage providers. The investigation revealed a coordinated effort to suppress post-acute care approvals to boost corporate profits. The records display a clear pattern of financial optimization through software.

• UnitedHealthcare: The company saw its prior authorization denial rate for post-acute care rise from 10. 9 percent in 2020 to 22. 7 percent in 2022. This increase coincided with the company shifting to more automated processes. UnitedHealthcare executives reported 2024 revenues nearing $300 billion and projected the figure to reach $340 billion in 2025.
• Humana: The insurer recorded a denial rate for post-acute care 16 times higher than its in total denial rate in 2022. The company also denied 54 percent more prior authorization requests for long-term acute care hospitals between 2020 and 2022.
• CVS Health: Operating through Aetna, the company maintained a stable denial rate for post-acute care from 2019 to 2022. Yet the total volume of prior authorization requests surged by 57. 5 percent during the same period. CVS and UnitedHealthcare both denied post-acute care requests at rates three times higher than their denial rates for other types of medical care.

These automated rejections transfer massive financial costs directly to medical providers. The Senate report indicates that appealing these algorithmic denials costs healthcare providers more than $7. 2 billion in administrative expenses each year. Providers must allocate extensive resources to fight software generated rejections, while insurers retain the premium payments.

Comparative Financial and Denial Metrics (2020 to 2024)

The financial strategy relies on the friction of the appeal process. A lawsuit filed against UnitedHealthcare and Humana alleges their shared algorithm has a 90 percent error rate. This means nine out of ten denials are reversed when a patient or doctor actually files an appeal. The profit model succeeds because the 0. 2 percent appeal rate ensures the insurer rarely has to pay for the reversed decisions. The software acts as a financial filter. It stops payments at the report stage and relies on patient exhaustion to finalize the savings.

Visualizing the Profit Margin of Algorithmic Friction

The financial architecture of these systems relies on shifting the administrative workload from the insurer to the patient and the physician. When a human medical director reviews a file, the insurance company pays for the time and expertise required to make a clinical judgment. By replacing this process with batch approvals, the insurer eliminates its own internal review costs. The responsibility to prove medical need then falls entirely on the provider. The provider must gather documentation, write appeal letters, and spend hours on the phone with insurance representatives. This asymmetrical workload guarantees that a massive percentage of denied claims remain unchallenged. The insurer retains the premium payments collected from the patient while simultaneously avoiding the cost of the medical care.

The volume of these operations generates massive capital reserves. When an algorithm denies 300, 000 claims over a two month period, the aggregate value of those unpaid bills creates an immediate cash flow advantage for the insurer. The company can invest this retained capital, generate interest, and report higher quarterly earnings to shareholders. The financial statements from these major insurers reflect this reality. The continuous growth in revenue and profit margins aligns perfectly with the adoption of automated denial systems. The software acts as a highly report tollbooth, stopping payments at the source and requiring patients to navigate a complex administrative maze to access their benefits.

The legal scrutiny surrounding these practices focuses heavily on this financial imbalance. Class action lawsuits filed against these major insurers claim that the companies intentionally deploy algorithms with high error rates because they know the appeal rate is statistically insignificant. The plaintiffs allege that the insurers prioritize financial metrics over clinical accuracy. The internal documents revealed during these investigations support this assertion. The presentations and spreadsheets track the number of denials, the time spent per claim, and the projected cost savings. They do not track the clinical outcomes or the health impact on the patients who receive the rejection letters.

The financial metrics show a clear correlation between the deployment of sorting software and increased corporate revenue. Cigna executives have publicly defended the system as a simple sorting technology used to match codes. They state that claims declined via PXDX account for less than one percent of their total claim volume. Yet even this small percentage equals hundreds of thousands of unpaid medical bills. The aggregate value of these unpaid bills directly supports the multi-billion dollar revenue streams reported to shareholders each quarter.

State insurance commissioners have begun to notice the financial impact of these systems. Mike Kreidler, the insurance commissioner for Washington, reviewed records for customer complaints describing auto-denial processes. He stated that it is an abhorrent practice to routinely deny claims just to enhance the bottom line. The financial data confirms that the bottom line is exactly what these systems protect. Every algorithmically generated rejection letter serves as a tiny deposit into the corporate treasury.

Architects of the Algorithm

Internal corporate records and statements from former executives reveal the exact origins of the PXDX system. Dr. Alan Muney built the framework in 2010. Muney previously managed health insurance for companies owned by the private equity firm Blackstone. Cigna hired him to identify financial savings within its operations.

Muney designed PXDX to bypass the traditional medical review process. Traditional rules required a nurse to screen a claim before a medical director evaluated the file. Muney eliminated that requirement for specific procedures. He stated that requiring company doctors to manually review each claim rejection would create an administrative hassle. He noted that manual reviews would force the company to hire more medical directors. Muney defended the automated batching method by stating it prevented unnecessary administrative expense. He explicitly confirmed the operational reality to reporters. He stated that PXDX decisions are not reviewed by a doctor or a nurse.

The Productivity Dashboard

Cigna enforced the batch denial process through strict internal tracking. Management deployed a spreadsheet known internally as the productivity dashboard. This document tracked the exact number of patient claims processed by each medical director every month. The spreadsheet featured a specific column headlined “PxDx” to tally automated denials.

The company assigned a specific handle time to each task. Management defined this metric as the average time required to finalize a decision. Medical directors understood this number as a strict maximum time limit. The dashboard ranked more than 70 doctors against their peers.

Dr. Debby Day worked as a Cigna medical director and openly questioned the speed requirements. In February 2019, Day sent emails to her managers regarding the pressure to process cases rapidly. Her supervisor responded by stating that management understood the volume of cases. The supervisor claimed the company accounted for additional time in the allotted schedule.

Day continued to fall behind her peers on the productivity dashboard. In January 2022, only one third of her colleagues recorded lower processing scores. By February 2022, only one quarter of the medical directors ranked report her. Day complained in recorded phone calls and emails that the metrics ignored the quality of medical decisions. She asked her superiors for data regarding overturned appeals. Management refused to provide those numbers. Cigna subsequently placed Day on a performance improvement plan. The company stated the plan was necessary to help her meet basic standards. Day refused to alter her review methods and eventually left the company.

The Ten Second Batch Protocol

The productivity metrics created a culture where medical directors processed denials in massive batches. One former Cigna doctor detailed the exact mechanical process required to meet company quotas. The doctor stated that medical directors literally click and submit. The system allowed a single physician to sign off on 50 denials in exactly 10 seconds.

Corporate executives knew the system operated on the edge of regulatory compliance. Insurance laws in multiple states require a licensed physician to conduct a thorough and objective evaluation of each patient file before denying care. A former Cigna executive admitted that internal leadership thought the batch denial process might fall into a legal gray zone. Management sent the PXDX proposal to the corporate legal department. The legal team reviewed the batching protocol and approved it for deployment.

The financial model relied heavily on patient attrition. Internal data showed that patients rarely fight back against automated rejections. Cigna executives expected only five percent of patients to appeal a denied claim. The algorithm specifically targeted low cost treatments. Patients frequently choose to pay a few hundred dollars out of pocket rather than navigate the corporate appeals process.

Cost Benefit Analysis: The 2014 Autonomic Testing Memo

Internal documents from 2014 demonstrate exactly how Cigna calculated the financial value of the PXDX list. Corporate planners evaluated the addition of autonomic nervous system testing to the automated denial algorithm. Doctors use this noninvasive test to detect nerve damage caused by diabetes and autoimmune diseases.

The procedure costs a few hundred dollars per patient. Cigna analysts calculated the exact financial impact of adding the test to the PXDX list. The internal memo projected that the algorithm would automatically deny payment for more than 17, 800 claims annually. The document calculated that these automated rejections would save the company 2. 4 million dollars every year.

Management acknowledged the possibility of negative customer experiences. They knew the automated denials would increase out of pocket costs for patients. Cigna added the autonomic nervous system test to the PXDX list anyway.

Targeted Procedures and Corporate Justification

Cigna expanded the PXDX algorithm to cover approximately 50 specific low cost tests and procedures. The company publicly defended the system as a simple tool to accelerate physician payments. Corporate statements claimed the software simply matched submitted codes against publicly posted clinical coverage policies.

The algorithm specifically targeted routine screenings. Cigna applied the automated denial system to vitamin D tests. The company stated that vitamin D testing is not medically necessary unless the patient has one of 200 specific diagnosis codes. The algorithm also targeted dermatological procedures like chemical peels and dermabrasion.

The chart report details the specific procedures targeted by the PXDX algorithm and the internal financial metrics associated with those denials.

Regulatory Conflict and the Legal Defense

The internal directives directly conflicted with established state insurance regulations. California law mandates that medical professionals conduct a thorough, fair, and objective investigation of every patient claim. State regulators in Maryland also raised alarms regarding the automated batching system. Maryland insurance officials stated that the algorithm raised red flags under state laws regulating group health plans. These laws require insurance company doctors to remain objective and flexible when evaluating each individual case.

Regulators stated that rubber stamping the output of matching software violates the core duty of a medical director. The automated system removes human medical judgment from the equation. Cigna executives defended the practice by stating the software only verifies that submitted codes match publicly available coverage policies. The company claimed the process accelerates physician reimbursement.

Cigna maintained that the automated review occurs after patients receive treatment. The corporate communications team claimed that the algorithm does not result in any denials of care. This defense relies on a specific technicality. The patient receives the medical treatment report. The algorithm then denies the payment for that treatment. The patient is left with an unexpected medical bill.

The Appeals Process and Patient Attrition

The financial success of the PXDX algorithm depends entirely on patient behavior. Internal corporate documents reveal that Cigna built the system with a clear understanding of the appeals process. The company knew that patients rarely challenge denied claims.

Cigna executives calculated that only five percent of patients would file an appeal after receiving a PXDX denial. The algorithm specifically report tests and treatments that cost a few hundred dollars. Former employees confirmed that insurers understand patient psychology. Patients frequently grumble about a denied claim report eventually write a check to cover the balance. The time and effort required to navigate the corporate appeals process deters most individuals.

When patients do appeal, the results frequently expose the flaws in the automated system. One prominent case involved a patient who received a denial for a vitamin D test. The algorithm rejected the claim because the patient did not have a previously documented vitamin D deficiency. The patient could not document the deficiency without the exact test that Cigna denied. The patient appealed the decision to an independent reviewer. The external reviewer overturned the Cigna denial after seven months. The blood test confirmed the patient actually suffered from a severe vitamin D deficiency.

The Corporate Response to Public Scrutiny

Cigna faced intense public scrutiny after the internal memoranda became public. The company released statements calling the reporting biased and incomplete. Corporate spokespersons insisted the PXDX system was a simple tool designed to accelerate payments for routine screenings.

The company published a defense of the algorithm on its corporate website. Cigna claimed that 94 percent of claims subject to the review process are automatically approved. The insurer stated that denied claims represent less than one percent of total volume. The company also stated that its procedures mirror processes used by the Centers for Medicare and Medicaid Services.

Former Cigna executives rejected this public defense. One former executive noted that the company previously paid all of these claims before implementing the algorithm. The executive stated that the system was explicitly built to deny claims and generate corporate savings. The internal productivity dashboards and the 2014 autonomic testing memo directly contradict the public narrative. The documents prove that Cigna measured success by the speed of automated rejections and the millions of dollars saved through patient attrition.

The Appeal Rate Drop Off

Patients rarely fight back against automated rejections. Data from the Kaiser Family Foundation in January 2025 shows consumers appeal fewer than one percent of denied in network claims. Internal corporate documents show Cigna projected only five percent of patients would appeal a PXDX denial. Other industry analyses reveal an even lower baseline. report algorithmic denial systems see an appeal rate of just 0. 2 percent. This means 99. 8 percent of patients accept the rejection. They either pay out of pocket or abandon their prescribed medical care. The financial model relies on this exact attrition rate. Every unappealed claim becomes a permanent denial and a retained profit for the insurer. The American Medical Association reported in 2025 that physicians spend an average of 12 staff hours per week handling 43 prior authorization requests. This administrative load discourages clinics from pursuing complex appeals for low cost procedures. The PXDX list flags tests and treatments that report cost a few hundred dollars. Insurers calculate that patients and doctors do not spend hours fighting over small dollar amounts.

Reversal Statistics

When patients do challenge these determinations, they win at high rates. A February 2026 report from the AAPC Knowledge Center indicates a 90 percent reversal rate on appeals for algorithmic denials. This metric suggests the automated system is incorrect nine times out of ten. Medicare Advantage data from 2024 shows similar outcomes. Patients overturned more than 80 percent of appealed prior authorization denials. A 2024 survey published in the American Journal of Managed Care found 50 percent of all individuals who disputed coverage denials secured approval for report or all of their denied services. Success rates climbed to 61 percent for Medicare beneficiaries and 46 percent for Medicaid recipients. The high frequency of overturned decisions exposes the inaccuracy of the initial automated review. Medical directors who process thousands of rejections a month rely on the algorithm rather than clinical evidence. The reversal data proves that human review during the appeal stage frequently contradicts the initial machine determination.

Department of Labor and Regulatory Findings

Federal regulators recognize this bottleneck. The Employee Retirement Income Security Act Advisory Council held hearings in July 2024 to evaluate health plan claim denials. Witnesses testified that the appeals process is needlessly complicated and hidden. The Leukemia and Lymphoma Society presented data to the council showing patients appeal only 90, 000 of 48 million denied claims. A Commonwealth Fund report from August 2024 found 45 percent of patients who did not challenge their denial were unsure if they had the right to do so. Another 40 percent did not know who to contact to initiate an appeal. The Department of Labor noted that while urgent care appeals must be decided in 72 hours, insurers routinely second guess legally binding urgent status determinations from physicians. The council heard testimony that report claim denials for smaller amounts of money never get challenged because hiring an attorney is not economical. This creates a functional immunity for insurers denying low cost claims in bulk.

State Variances in Cigna Denials

Denial rates fluctuate wildly depending on the state and the specific health plan. A 2025 Kaiser Family Foundation analysis found federal exchange insurers denied 19 percent of in network claims and 37 percent of out of network claims in 2023. The in network denial rate ranged from one percent to 54 percent across different insurers. Cigna HealthCare of North Carolina attributed 30 percent of its denial reasons to clinical requirements. Legal data from the Law Offices of Scott Glovsky highlights extreme regional differences. Cigna Silver EPO plans in Tennessee denied 37 percent of claims for clinical reasons. Cigna Silver EPO plans in Virginia denied 28 percent of claims for the same reason. In contrast, denial rates in states like California and Nevada hovered near two percent. These geographic differences indicate that denial algorithms apply different thresholds based on local regulatory environments rather than universal medical standards.

Cigna Corporate Defense

Cigna maintains a different interpretation of these metrics. The company published a defense of the PXDX system on its corporate newsroom site. Cigna states the procedure to diagnosis software is not prior authorization. The insurer claims the tool only applies to a small group of approximately 50 low cost tests and procedures. According to Cigna, the system automatically approves and pays 94 percent of claims subject to this review. The company asserts that claims denied through this process represent less than one percent of its total claim volume. Cigna instructs providers to resubmit denied claims with an updated diagnosis code or file a formal appeal. The company states that post service reviews ensure compliance with publicly posted clinical coverage policies. They state that patients are not denied care because the review occurs after the patient receives treatment. This shifts the financial risk entirely to the patient and the provider.

The Financial Toll of the Appeals Process

The appeals process extracts a massive financial toll on the healthcare system. Data published by CareYaya in 2025 shows administrative costs consume 800 billion dollars annually. This represents 34 percent of total United States healthcare spending. Hospitals and clinics spent 25. 7 billion dollars in a single year contesting insurance claim denials. American hospitals report employ more billing specialists than beds. The friction created by automated denial systems forces medical providers to divert resources from patient care to administrative combat. When a Cigna medical director denies a claim in 1. 2 seconds, the provider must spend hours gathering medical records, drafting appeal letters, and navigating the insurer portal. This asymmetry in effort guarantees that report valid claims expire without an appeal. The system weaponizes administrative fatigue.

Patient Impact and Medical Debt

The consequences of unappealed denials fall directly on patients. A 2024 Commonwealth Fund survey revealed that nearly six of ten adults who experienced a coverage denial said their care was delayed as a result. Nearly half of the respondents who experienced a delay reported that their health problem got worse. When patients do not appeal, they face unexpected medical bills. The CareYaya report notes that 100 million Americans carry medical debt. Approximately 550, 000 families file for bankruptcy annually due to medical costs. The PXDX system flags low cost procedures, report these small bills accumulate rapidly for patients with chronic conditions. The strategy of denying claims after treatment leaves the patient legally responsible for the balance. Providers send these unpaid balances to collections, damaging patient credit scores and discouraging future medical visits.

Statistical Breakdown of Claim Denials and Appeals

State Regulatory Investigations into Automated Denials

State insurance regulators initiated formal investigations into the PXDX algorithm throughout 2024 and 2025. Officials scrutinized the automated system for violating fair claims settlement practices and state laws requiring individualized medical review.

California Department of Managed Health Care

The California Department of Managed Health Care levied a $500, 000 fine against Cigna HealthCare of California in October 2025. The department found the company improperly reviewed and denied health care claims. Regulators determined Cigna rejected provider submissions without physicians conducting clinical reviews prior to issuing the denials. The state ordered the company to pay the penalty and review denied claims again dating back two years.

The California investigation focused specifically on retrospective review. This process involves handling health care claims payments submitted by providers after medical services are already complete. The department found the medical need review process for a subset of provider claims failed to comply with the filed policy of the plan. California law mandates that health plans maintain written policies detailing how they modify or deny claims based on medical need. Cigna used a different review process than the one it officially filed with the state.

DMHC Director Mary Watanabe stated that the stability of the health care delivery system suffers when health plans wrongly deny payment for services. She affirmed that health plans must have licensed medical experts review claims prior to denying them for an absence of medical need. California lawmakers also enacted Senate Bill 1120. The legislation took effect on January 1, 2025. The law strictly prohibits health insurers from denying or modifying coverage for medically necessary treatment based solely on an automated tool. Any adverse benefit determination report requires individual review by a licensed clinician.

Delaware Department of Insurance

The Delaware Department of Insurance published a market conduct examination report on March 31, 2024. The inquiry scrutinized the internal operations of the PXDX system. State examiners asked the company to provide the average time medical directors spent reviewing PXDX cases. Cigna representatives told regulators they send PXDX claims to medical directors for review within two business days. Yet the company could not provide data showing how long the medical director actually spends reviewing the decisions. The absence of this time tracking data became a focal point for state officials evaluating compliance with fair claims practices.

Examiners identified multiple compliance failures during the audit. The state found Cigna failed to transmit appeals to the department within the required three business days. Regulators documented seven specific exceptions related to this delay. The audit also revealed the company subjected members to deductibles and copayments for chronic care management. Delaware law strictly prohibits charging patients these fees for chronic care coverage. Examiners noted 34 exceptions where Cigna violated this specific statute.

Connecticut Insurance Department

The Connecticut Insurance Department holds primary jurisdiction over Cigna as its domestic regulator. The department scheduled a market conduct examination to scrutinize the utilization review practices of the company. State examiners reviewed a sample period to verify compliance with statutory requirements. The investigation included a specific focus on the PXDX system following public reports of bulk denials.

Cigna executives responded to the department by stating the algorithm is not used for insured businesses within Connecticut. The company claimed the system only processes post service claims for members outside the state. The department advised consumers to contact its Consumer Affairs Division to report any automated denial problems. State regulators maintained their authority to investigate whether the post service denials violate fair claims settlement laws. The department requires insurers to conduct a reasonable investigation based on all available information before denying a claim. Automated batch denials inherently conflict with this statutory requirement for individualized investigation.

Maryland Insurance Administration

Maryland state insurance officials publicly questioned the legality of the PXDX system. Regulators stated the algorithm raises red flags regarding compliance with state laws. Maryland requires insurance company doctors to remain objective and flexible when evaluating each patient case. Officials warned that rubber stamping the output of matching software without additional review makes it difficult for medical directors to comply with state mandates.

New York Department of Financial Services

The New York Department of Financial Services took preemptive action against algorithmic denials. The agency issued Insurance Circular Letter Number 7 on July 11, 2024. The directive applies to all insurers authorized to write policies in the state. The mandate covers the use of artificial intelligence and machine learning in underwriting and claims processes.

The directive established strict expectations for transparency and justification from insurers using algorithmic systems. Regulators mandated that any use of automated matching software must comply with antidiscrimination laws. Insurers operating in New York must prove their automated claims decision processes do not violate state insurance laws. Companies must conduct regular testing to ensure their algorithms do not produce discriminatory outcomes. The state mandates that insurers maintain detailed records of these tests for regulatory review.

Federal and National Association Guidelines

The National Association of Insurance Commissioners published a framework to guide state regulators in 2024. The consortium warned that automated tools frequently worsen bias against marginalized communities. The report noted that algorithms learn from historical datasets. This process creates a feedback loop where technological speed becomes a method for deepening health care inequality. The association directed state departments to mandate detailed disclosure of training data and decision criteria. Regulators must also demand documentation of clinical justification whenever an algorithm overrides a physician recommendation.

Federal authorities at the Centers for Medicare and Medicaid Services implemented parallel regulations in January 2024. The federal agency report requires Medicare Advantage plans to base coverage decisions on individual patient circumstances rather than algorithmic predictions. Coverage denials must undergo review by physicians with relevant clinical expertise. State insurance commissioners frequently use these federal guidelines as a baseline for local enforcement. CMS Deputy Administrator Meena Seshamani announced audits and enforcement actions for non compliance. Penalties include civil fines and enrollment suspensions for insurers failing to meet the individual review standards.

Summary of State Regulatory Actions

The Preemption Shield and Administrative Exhaustion

Cigna relies on the Employee Retirement Income Security Act of 1974 to defend its automated medical justification reviews. The federal statute governs employer provided benefit plans. Corporate legal teams use the law to move state level consumer protection lawsuits into federal courts. Federal judges then dismiss the state claims through a legal doctrine called express preemption. The strategy forces patients to fight the insurer under strict federal rules that limit financial damages to the exact cost of the denied medical service.

A May 31, 2024 ruling by the Ninth Circuit Court of Appeals demonstrates this tactic. In the case of Bristol SL Holdings versus Cigna Health and Life Insurance Company, the insurer refused to reimburse 8. 6 million dollars for 106 patients. The treatment center staff called the insurer to verify coverage before admitting the patients. The insurer authorized the treatments over the phone. The facility provided the medical care and submitted the bills. The insurer later refused to pay the balance. The insurer accused the facility of waiving patient cost sharing requirements. The facility sued the insurer for breach of oral contract under state law. The Ninth Circuit ruled that the federal statute preempted the state contract claims. The court decided that verifying coverage over the phone did not create an independent contract. The ruling established that medical providers cannot rely on state contract law to enforce verbal payment authorizations from the insurer.

The internal appeals process serves as the report line of defense for the insurer. Federal courts strictly enforce the exhaustion of administrative remedies doctrine. Patients must submit multiple rounds of appeals directly to the company that denied their initial claim. The insurer controls the timeline and the evidence allowed in the administrative record. If a patient files a lawsuit before completing every internal appeal step, federal judges dismiss the case immediately. The Benson versus Tiffany and Company case from the Southern District of New York illustrates this strict compliance standard. The court dismissed a benefit claim because the patient missed the 60 day appeal deadline by six days. The insurer uses these rigid procedural rules to filter out claims before they reach a judge.

The 2025 Fiduciary Breach Ruling

Patients filed a class action lawsuit against Cigna in the Eastern District of California. The case is Kisting Leung versus Cigna Corporation. The plaintiffs alleged that the software instantly rejected claims on medical grounds without human review. One plaintiff requested coverage for a transvaginal ultrasound. The medical coverage policy of the insurer classified the procedure as medically justified for patients at risk for certain cancers. The software denied the claim. The plaintiff sued for wrongful denial of benefits. The defense lawyers stated that the medical coverage policy does not constitute a binding plan document. The judge agreed with the defense. The court ruled that plaintiffs must quote the exact text from their specific employer plan that guarantees coverage for the procedure. This ruling forces patients to obtain and analyze complex legal documents before filing a lawsuit.

On March 31, 2025, United States District Judge Dale Drozd issued a ruling on the motion to dismiss filed by the insurer. The judge granted the motion in part and denied it in part. The court dismissed the wrongful denial of benefits claims. The judge ruled that the plaintiffs failed to identify the specific plan terms that entitled them to the requested medical services. The plaintiffs relied on the medical coverage policy of the insurer instead of the actual plan documents.

Yet the judge allowed the breach of fiduciary duty claims to proceed. The court examined the plan documents. The documents required a medical director to make medical justification decisions. The plaintiffs alleged that the software made the decisions instead of a medical director. The judge ruled that delegating this authority to an algorithm could constitute an abuse of discretion and a breach of fiduciary duty under federal law. This ruling opened a legal pathway for patients to challenge the automated system.

Standing and the load of Proof

The insurer aggressively challenges the legal standing of the plaintiffs. Corporate lawyers demand proof that the algorithm processed the specific claims of the named plaintiffs. In the Kisting Leung case, the insurer submitted a sworn declaration from Dr. Julie B. Kessel. The doctor serves as a medical officer in the Clinical Performance and Quality department of the insurer. The declaration stated that the algorithm did not process the claims of three specific plaintiffs.

The judge accepted this factual attack on standing. The court dismissed the algorithm based claims for those three plaintiffs. This defense tactic forces plaintiffs to obtain internal corporate records to prove the exact method of their denial. Patients rarely possess this information when they file a lawsuit. The insurer uses this information asymmetry to secure early dismissals.

Statutory Defenses and Court Outcomes

The legal battles center on specific sections of the federal statute. The insurer deploys distinct defenses for each type of claim. The table report outlines the primary legal statutes, the defense strategy of the insurer, and the outcomes from the March 2025 federal court ruling.

The insurer successfully defeated the state law claims. The plaintiffs claimed that California law requires a licensed physician to evaluate medical justification. The judge agreed with the insurer that the federal statute expressly preempts the state law claim. The court ruled that state laws cannot regulate the administration of federal benefit plans. This preemption blocks state regulators from enforcing medical review standards on employer provided health plans.

The Fiduciary Duty Vulnerability

The survival of the fiduciary duty claims presents a new legal risk for the insurer. Federal law requires plan administrators to act solely in the interest of the plan participants. The plan documents explicitly stated that a medical director would review claims for medical justification. The plaintiffs presented evidence that the software processed the claims in batches. The judge determined that replacing a human medical director with an automated script could violate the fiduciary duties of the insurer. The court noted that the insurer cannot grant itself the discretion to ignore its own written procedures. This specific ruling allows the plaintiffs to demand internal corporate communications regarding the software deployment.

The upcoming legal battles focus on the discovery phase. The plaintiffs plan to demand the source code and the decision trees used by the software. The insurer fights to keep these technical details sealed. Corporate lawyers frequently request phased discovery to delay the release of proprietary algorithms. The defense claims that the software only flags claims for review and does not make final medical determinations. The plaintiffs must prove that the software operates autonomously to deny care. The outcome of this discovery process determines the viability of future class action lawsuits against automated medical review systems. The insurer seeks to bifurcate the discovery process to limit access to the algorithm data. The legal strategy of the insurer relies on separating individual claims and preventing a broad review of the automated denial process.

The Algorithmic Precedents: Comparing PXDX to Automated Denial Software at Rival Health Insurers

Cigna is not the only health insurance company deploying software to reject medical claims. Competitors use similar logic to deny coverage. A review of court records and federal data between 2015 and 2025 shows a clear pattern across the industry. UnitedHealthcare, Humana, and Elevance Health operate automated systems that restrict patient care. A 2024 survey by the National Association of Insurance Commissioners found 84 percent of 93 large health insurers use artificial intelligence for operational purposes. The American Medical Association recorded an average denial rate of 17 percent for medical claims. The Affordable Care Act marketplace insurers denied nearly one in five in network claims in 2023. This represents an increase from a 17 percent denial rate in 2021.

UnitedHealthcare and the nH Predict Algorithm

UnitedHealthcare faces a class action lawsuit filed in November 2023 over its use of the nH Predict algorithm. The software, developed by the Optum subsidiary NaviHealth, estimates the required length of stay for patients in post acute care facilities. Plaintiffs allege the company uses these estimates to cut off Medicare Advantage coverage prematurely. The lawsuit claims the nH Predict tool carries a 90 percent error rate when patients appeal the decisions. Yet the company knows only 0. 2 percent of policyholders actually file an appeal. This report allows the insurer to retain the financial savings from the initial rejections.

Internal report at UnitedHealthcare reportedly required clinical employees to keep patient rehabilitation stays within one percent of the days projected by the nH Predict algorithm. Employees who deviated from the software recommendations faced disciplinary action or termination. Federal data indicates UnitedHealthcare denied nearly one third of all in network claims in 2022. A 2024 Senate investigation found the company denial rate for post acute care claims more than doubled after it deployed NaviHealth and nH Predict. The Senate Permanent Subcommittee on Investigations published a report in October 2024 showing UnitedHealthcare, Humana, and CVS denied prior authorization requests for post acute care at a higher rate than their in total denial rates between 2019 and 2022.

In March 2026, a federal magistrate judge in Minnesota ordered UnitedHealth Group to produce documents dating back to January 2017. The judge ordered the release of performance evaluation and compensation records for post acute care coordinators and medical directors. The court also demanded documents related to the internal artificial intelligence review board. Optum rebranded NaviHealth to Home and Community Care in 2024. Optum claims the tool is a care support tool that factors in patient cognition, mobility, and ability to perform daily activities. The company maintains the software does not make final coverage determinations.

Humana Deploys the Same NaviHealth Software

Humana also uses the nH Predict algorithm to process Medicare Advantage claims. A December 2023 lawsuit filed by the Clarkson Law Firm in the United States District Court in Western Kentucky accuses Humana of illegally deploying the software to override treating physicians. Humana provides Medicare Advantage plans for 5. 1 million eligible Americans. The complaint states Humana employees face termination if they deviate from the algorithm projections. The plaintiffs allege the company uses the software to force elderly patients out of skilled nursing facilities before they complete their medical recovery.

One plaintiff in the Humana case, an 86 year old woman from Minnesota, suffered a fractured leg. Her doctor prescribed a six week treatment plan. Humana stopped paying for her post acute care after two weeks based on the algorithm output. The patient paid out of pocket for an assisted living facility where her condition worsened. The lawsuit accuses Humana of banking on beneficiaries not appealing denials. A survey by the non profit KFF found less than 0. 2 percent of people purchasing insurance through the federal marketplace appeal in network claims that are denied.

Elevance Health and Automated Claim Rejections

Elevance Health, formerly Anthem, faces separate legal actions regarding its claims processing methods. In August 2023, the Bon Secours health system sued Anthem Blue Cross Blue Shield for 93 million dollars over unpaid claims. Bon Secours alleges Anthem uses heavy handed tactics to delay or deny reimbursement. The lawsuit accuses the insurer of downcoding emergency room claims and increasing special investigation unit audits. One Richmond area hospital received 15 special investigation letters covering more than 800 emergency room accounts over an eight week period. Bon Secours stated Anthem owes the system 85 million dollars in Ohio and 6 million dollars in Kentucky.

Elevance Health also reported higher denial rates for in network provider claims compared to the marketplace average. In December 2023, Elevance Health sued Health and Human Services over lower 2024 plan star ratings. In 2023, 64 percent of Elevance plans had four or five stars. In 2024, only 34 percent achieved that rating. Elevance claimed this drop lowers bonus payments by 500 million dollars. The company claimed the calculation changes were illegal.

Centene and the Payment Integrity Arms Race

Centene Corporation also uses artificial intelligence to manage claims. On a July 2025 earnings call, Elevance CEO Gail Boudreaux claimed hospitals use artificial intelligence to increase documented acuity and justify higher reimbursements. Centene CEO Sarah London responded by announcing her company deploys artificial intelligence in payment integrity to keep pace with provider side automation. This creates an arms race where algorithms deny claims and algorithms write the appeals. The patient remains caught in the middle of this automated crossfire.

The United States Department of Justice also report these insurers for other practices. The government filed a lawsuit against Aetna, Elevance Health, and Humana accusing them of paying kickbacks to brokers in exchange for steering enrollments into their Medicare Advantage plans. A separate 2020 Department of Justice lawsuit against Anthem alleged the company submitted tens of millions of dollars in fraudulent claims. These legal actions point to a broader pattern of prioritizing financial gains over patient care.

Comparing the Automated Denial Systems

The industry relies on software to process high volumes of medical requests. Cigna uses PXDX to match diagnosis codes with procedure codes. UnitedHealthcare and Humana use nH Predict to estimate recovery timelines. Elevance Health uses targeted audits and downcoding software. All four methods result in bulk rejections. The table report outlines the specific software and report used by the four major insurers.

The financial incentives driving these algorithms remain consistent across the sector. Insurers collect premiums while using software to limit payouts for medical services. The algorithms shift the administrative workload onto patients and doctors. Medical professionals must spend hours filing appeals for treatments they already deemed necessary. Patients must navigate complex bureaucratic systems while recovering from severe illnesses or injuries. The UnitedHealthcare and Humana lawsuits demonstrate the human cost of these automated systems. Elderly patients face eviction from rehabilitation centers when the algorithm dictates their recovery time is complete. The Elevance Health lawsuit shows how automated audits drain resources from hospital systems. Bon Secours reported losing 1. 2 billion dollars in 2022 while Elevance posted billions in profits.

State and federal regulators are beginning to examine these practices. In February 2024, the Centers for Medicare and Medicaid Services issued guidance clarifying that algorithms cannot solely dictate coverage decisions. The agency requires Medicare Advantage plans to base coverage decisions on individual circumstances rather than algorithmic predictions. A new California law went into effect on January 1, 2025, prohibiting payers from making coverage decisions based solely on artificial intelligence algorithms. Texas lawmakers introduced a bill to prohibit insurers from using artificial intelligence to delay or deny claims. These legislative actions show growing scrutiny of automated denial software across the health insurance industry.

Medical Association Responses to Algorithmic Claim Rejections

Physician advocacy groups and medical associations mobilized against automated claim rejections throughout 2024 and 2025. Medical professionals report that algorithmic systems bypass necessary clinical judgment. Organizations representing doctors, hospitals, and medical groups compiled data showing direct harm to patients and severe administrative report on medical practices. These groups transitioned from issuing warning statements to backing state legislation and publishing verified survey metrics that quantify the damage caused by automated denial engines.

The American Medical Association Prior Authorization Survey

The American Medical Association published its 2024 Prior Authorization Physician Survey in February 2025. The organization surveyed 1, 000 practicing physicians across the United States. The sample included 400 primary care doctors and 600 specialists. The data revealed widespread alarm regarding unregulated artificial intelligence in the claims process.

According to the American Medical Association report, 61 percent of surveyed doctors expressed fear that artificial intelligence systems increase prior authorization denials and override medical judgment. Seventy five percent of respondents reported an absolute increase in prior authorization denials between 2019 and 2024. The survey quantified the physical toll on patients. Twenty nine percent of physicians reported that prior authorization delays resulted in serious adverse events. These events included hospitalization, permanent impairment, or death.

The administrative load on medical practices reached new highs. Physicians reported completing an average of 39 prior authorizations per week. This workload consumes 13 hours of staff time weekly. Eighty nine percent of respondents stated that prior authorization requirements contribute to physician burnout. Ninety four percent of doctors noted that the prior authorization process negatively impacts clinical outcomes. Eighty two percent of physicians observed patients abandoning their recommended treatment entirely due to authorization delays.

The American Medical Association specifically tracked insurer pledge to reduce administrative friction. Cigna and UnitedHealthcare announced reductions in the number of services requiring prior authorization in 2023. Yet the 2025 survey showed these announcements did not translate to operational relief. Only 16 percent of physicians working with Cigna reported any actual reduction in their prior authorization workload.

American Medical Association President Dr. Bruce A. Scott addressed the survey results in a March 2025 statement. He noted that insurers use automated decision making systems to execute batch denials with zero human review. He stated that medical decisions must remain between physicians and patients without interference from unsupervised technology.

The California Medical Association Legislative Action

The California Medical Association took direct legislative and administrative action against algorithmic denials. The organization backed California Senate Bill 1120. Lawmakers enacted the bill in 2024. The law took effect on January 1, 2025. The legislation prohibits health insurers from denying, delaying, or modifying coverage for medically necessary treatment based solely on an algorithm or automated tool. The law mandates that any adverse benefit determination affecting patient care must receive an individual review by a licensed clinician.

The California Medical Association also contested specific Cigna policies. The physician group argued that Cigna deployed algorithms absence transparency. They warned that these automated systems chance violated state laws regarding payment timelines. Following this organized pushback, Cigna agreed to pause the implementation of certain automated review policies. The insurer delayed the rollout until October 1, 2025, pending further review. Cigna framed the paused measure as an anti fraud initiative, while the California Medical Association viewed it as an unlawful expansion of automated denials.

The Medical Group Management Association Revenue pattern Data

The Medical Group Management Association tracks the financial health of medical practices. The organization identified algorithmic claim denials as a primary threat to practice viability. A Medical Group Management Association survey found that 69 percent of medical groups identified increased denials as their top revenue pattern challenge.

The organization reported that 89 percent of medical groups classify prior authorization as very or extremely burdensome. The Medical Group Management Association noted that the absence of internal resources to fight automated denials contributes heavily to revenue loss. Medical practices must hire dedicated staff to appeal algorithmic rejections. Forty percent of physicians report employ dedicated personnel exclusively to handle prior authorization tasks and appeals.

The Medical Group Management Association data shows that fighting automated denials costs providers an estimated 7. 2 billion dollars annually in administrative overhead. Rural hospitals and independent practices face the highest risk. These smaller entities operate with thin margins and cannot afford the administrative staff required to appeal batch denials.

The American Hospital Association Denial Metrics

The American Hospital Association tracks claim rejections at the institutional level. The organization reported that claim denials increased by more than 20 percent between 2019 and 2024. The American Hospital Association attributes this surge directly to the insurance industry deploying artificial intelligence automation to review claims.

Hospital administrators report that automated systems prioritize speed and cost reduction over accuracy. The American Hospital Association data aligns with the physician surveys. Insurers deny claims by default using automated parameters. Hospitals must then dedicate massive resources to the appeals process. The Consumer Financial Protection Bureau noted that medical debt affects over 100 million Americans, a metric exacerbated by the rising rate of automated insurance denials.

The American Society of Clinical Oncologists Guidelines

Specialty medical societies also established new frameworks to combat algorithmic interference. The American Society of Clinical Oncologists published its Principles for the Responsible Use of Artificial Intelligence in Oncology in May 2024. The organization demanded transparency in how insurers deploy algorithms to determine cancer treatment coverage.

Oncologists face unique challenges with automated denials. Cancer treatments require rapid approval. Algorithmic rejections delay chemotherapy and radiation report. The American Society of Clinical Oncologists guidelines insist that artificial intelligence must only augment human decision making. The society strictly opposes the use of algorithms as autonomous denial engines for oncology claims.

Centers for Medicare and Medicaid Services Final Rule Reactions

The Centers for Medicare and Medicaid Services issued the Interoperability and Prior Authorization Final Rule on January 17, 2024. The federal agency designed the rule to improve the electronic exchange of health information. The mandate requires payers to send prior authorization decisions within 72 hours for expedited requests and within seven calendar days for standard requests starting in 2027.

Medical associations viewed the federal rule as a necessary baseline report argued it did not go far enough to restrict algorithmic denials. The American Medical Association and the American College of Physicians noted that faster processing times do not solve the underlying problem of automated rejections. If an algorithm denies a claim in one second, a 72 hour deadline provides no additional protection for the patient.

The federal agency issued a clarifying Frequently Asked Questions document on February 6, 2024. The guidance stated that Medicare Advantage plans must base coverage decisions on individual patient conditions. Insurers must support their decisions with medical notes, patient history, and provider recommendations. Medical associations use this federal guidance to challenge commercial insurers like Cigna, arguing that algorithmic batch denials violate the principle of individualized medical review.

Summary of Medical Association Demands

The shared pushback from these medical associations centers on three specific demands. report, organizations require full transparency regarding the algorithms insurers use to evaluate claims. Second, medical societies demand that a licensed physician review every denied claim before the insurer problem the rejection. Third, associations insist on financial penalties for insurers that deploy algorithms with high error rates.

The medical community transitioned from passive observation to active resistance between 2024 and 2025. Organizations like the American Medical Association and the California Medical Association proved that algorithmic denials cause measurable harm to patients and financial damage to medical practices. Their published data and legislative victories form the foundation of the ongoing regulatory battle against automated insurance rejections.

Legislative Mandates Restricting Automated Claims Processing

State governments intervened directly following the exposure of the Cigna algorithm. California Governor Gavin Newsom signed Senate Bill 1120 into law on September 28, 2024. The legislation took effect on January 1, 2025. The new statute requires healthcare providers across the state to operate under a system where denials originate from actual physician review of individual patient records. The law mandates that any denial or modification of healthcare services based on medical need must involve a licensed physician or a qualified healthcare professional competent to evaluate the specific clinical details. This legal requirement directly outlaws the batch denial method previously used by systems like PXDX.

Other states introduced similar legislation in 2024. Lawmakers in Rhode Island and Texas proposed bills to restrict automated decision tools in clinical care. Pennsylvania legislators introduced a bill requiring insurers to disclose the use or absence of artificial intelligence algorithms on their websites. The Pennsylvania proposal demands that the state insurance department implement a process to certify that algorithms do not discriminate against protected groups. Insurers must submit their data to the department to avoid fines or license suspension.

Regulatory Fines and Consent Orders in Texas

The Texas Department of Insurance penalized Cigna multiple times in 2024 for failing to comply with state regulations. The state passed Senate Bill 1264 in 2019 to prohibit balance billing for most out of network health insurance claims. The law created a mediation and arbitration system for health insurers to settle balance bills with healthcare providers. The Texas Department of Insurance established an independent dispute resolution portal to implement this legislation.

Cigna failed to meet statutory timelines for a large volume of dispute resolution requests. The Texas Department of Insurance issued a consent order on June 6, 2024. Cigna agreed to pay a $600, 000 administrative penalty and implement a corrective action plan. The company pledged to achieve full compliance by August 15, 2024. Cigna failed to meet this deadline. The state agency found that Cigna continued to miss deadlines for participating in informal teleconferences and paying arbitrators. The Texas Department of Insurance issued a second consent order on December 20, 2024. The state ordered Cigna to pay an additional $800, 000 administrative penalty within 30 days.

Federal Settlements and Class Action Litigation

The United States Department of Justice secured a large settlement from Cigna in late 2023. Cigna agreed to pay $172. 3 million on October 5, 2023. The settlement resolved allegations that the company submitted inaccurate diagnosis codes for Medicare Advantage enrollees and failed to withdraw them. The Justice Department stated that Cigna failed to verify the accuracy of diagnosis codes reported by providers before submitting them to the Centers for Medicare and Medicaid Services. Cigna paid $135. 3 million to resolve the primary allegations and another $37 million to resolve claims related to unsupported diagnoses for enrollees receiving in home services.

Private litigation against Cigna evolved throughout 2024. Plaintiffs filed a Third Amended Class Action Complaint on June 14, 2024. The updated legal filings introduced claims under the Employee Retirement Income Security Act and the California Unfair Competition Law. The plaintiffs asserted that Cigna policies falsely claimed that determinations related to medical need would involve a medical director rather than an algorithm. The Employee Retirement Income Security Act requires plan fiduciaries to discharge their duties solely in the interest of the participants. The lawsuit alleges that the automated batch denial process violates this federal fiduciary duty. Cigna filed a motion to dismiss the lawsuit. The company asserted that the PXDX system simply checks whether specific treatments are covered by the benefit plan. Plaintiffs filed their opposition papers on September 20, 2024. Cigna submitted a reply on October 15, 2024. The United States District Court for the Eastern District of California continues to weigh the motion.

Cigna agreed to a separate $1. 07 million class action settlement in December 2025. The lawsuit alleged that the company misclassified out of network healthcare providers as in network. This error caused consumers to receive balance bills and face undercompensation for their medical expenses. The LocalPlus plan administered by Cigna processed these claims incorrectly due to a mistake in how the company configured the plan benefits. Class members who submitted proof of receiving a balance bill qualified for a cash payment under the settlement terms. The final approval hearing for the settlement is scheduled for early 2026. Cigna did not admit wrongdoing in the agreement.

Financial Penalties Linked to Cigna Claims Practices

State and federal agencies extracted millions in penalties from Cigna between late 2023 and 2025. The following data points track the exact financial levies imposed on the insurer.

Algorithm Adjustments and Internal Policy Shifts

The intense scrutiny forced Cigna to defend its internal processes. The company maintained that the PXDX system only evaluates claims after a patient receives treatment. Cigna representatives stated that the algorithm accelerates payments to clinicians for common tests and treatments. The insurer claimed that the system identifies mismatches between diagnoses and acceptable procedures without acting as an artificial intelligence tool.

The legal pressure exposed the exact mechanics of the algorithm. Court filings revealed that Cigna doctors signed off on denials in batches. The company did not disclose to members that the algorithm would deny their claims without direct doctor involvement. The Third Amended Class Action Complaint emphasized that Cigna policies guaranteed a medical director would determine medical need. The introduction of California Senate Bill 1120 and similar state laws report requires insurers to restructure these automated systems. Companies must ensure a licensed physician reviews the clinical details of every denied claim to comply with the new legal standards. The California law specifically report the use of artificial intelligence and automated decision tools in utilization review. This legislation forces health plans to abandon software that rubber stamps denials without human oversight.

The Texas Department of Insurance enforcement actions also forced Cigna to alter its administrative operations. The company agreed to implement additional controls and monitor its independent dispute resolution process. Cigna pledged to alert the state agency of any recurring errors. The state data showed that Cigna struggled to process requests from a single healthcare provider group in June and July of 2024. The company failed to finalize data corrections or fully implement its corrective action plan by the spring of 2024. The subsequent fines reflect the strict regulatory environment insurers report face when automating claims processing and dispute resolution. The Texas regulators demanded that Cigna assign proper resources to its dispute resolution program to prevent future delays. The state agency continues to monitor the company to ensure compliance with the mandated corrective action plan.